Reuters logo
BRIEF-Ashland Global reports Q2 EPS of $1.42 from continuing operations
April 25, 2017 / 10:02 PM / 8 months ago

BRIEF-Ashland Global reports Q2 EPS of $1.42 from continuing operations

April 25 (Reuters) - Ashland Global Holdings Inc

* Q2 adjusted earnings per share $1.71 from continuing operations

* Q2 earnings per share $1.42 from continuing operations

* Sees Q3 adjusted ebitda for Ashland Specialty Ingredients to be $123-$133 million, versus $128 million last year

* Qtrly sales $1,320 million versus $1,247 million - SEC filing

* For Q3, ASI sales are expected to be in range of $535-$565 million

* Ashland anticipates closing Pharmachem acquisition in June quarter

* With addition of Pharmachem's related income, now expect ASI's adjusted ebitda for fiscal 2017 to be in range of $485-$500 million Source text (bit.ly/2qbO3c8) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below